Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Arena Pharmaceuticals Inc (NASDAQ:ARNA)

1.71
Delayed Data
As of 4:00pm ET
 +0.06 / +3.64%
Today’s Change
1.30
Today|||52-Week Range
5.12
-10.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues27.6M81.4M37.0M38.3M
 
 
 
 
 
Cost of Goods Sold3.7M2.1M3.2M3.1M
 
 
 
 
 
Depreciation And Amortization9.7M8.2M9.2M10.0M
 
 
 
 
 
 
Operating ExpensesGross Income14.2M71.1M24.6M25.2M
 
 
 
 
 
General Expenses71.3M94.0M129.9M124.4M
 
 
 
 
 
Research And Development54.1M66.5M100.3M88.4M
 
 
 
 
 
Total Operating Expenses84.7M104.3M142.2M137.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-57.1M-22.9M-105.3M-99.2M
 
 
 
 
 
Extraordinary Credit0.0010.2M4.4M474.0K
 
 
 
 
Extraordinary Charge-19.8M0.000.00-4.0M
 
 
 
Interest Expense On Debt9.1M7.1M6.9M6.8M
 
 
 
 
 
Other Expenses400.0K352.0K47.2M1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-85.5M-19.4M-60.5M-108.0M
 
 
 
 
 
Preferred Dividend-2.8M0.000.000.00
 
 
Net Income-85.5M-19.4M-60.5M-108.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS196.5M218.1M219.7M240.7M
 
 
 
 
 
Shares To Calculate EPS Diluted196.5M218.1M219.7M240.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.45-$0.09-$0.28-$0.45
 
 
 
 
 
EPS Diluted-$0.45-$0.09-$0.28-$0.45